Educational research tool. Not investment advice. You are responsible for your own trading decisions.

Verdix.
← All analysis

Walmart Inc. (WMT)

Verdict history · WMT

Every call Verdix has made on WMT.

While a verdict holds, its return keeps accumulating from the day the call was made — it resets only when the verdict itself changes.

Click any date below to read that write-up

WaitSell· Aug 22, 2026

The prior WAIT at $115.27 anticipated a pullback into $75-$90 as a buying opportunity. Two post-earnings developments converted that patience play into a sell signal: first, the disclosure of nearly 3 million shares in concentrated insider selling during the six weeks before the print introduced a management-alignment question that did not exist in August; second, the 9% single-day drop on 1.8x average volume broke the stock decisively below all three weekly EMAs, shifting the technical structure from a healthy pullback to a Stage 4 decline. The price came down as hoped, but the manner of the decline changed the character of the trade.

See methodology for how verdicts are produced. Full track record →

The panel’s case against WMT — and where they disagree.

SellHIGH confidence

The case against outweighs the case for at today's price.

NYSE · Consumer Staples / Retail · 2026-08-22 · analysis, not advice

Key levels and fundamentals figures are sourced from public market data and filings. All panel verdicts, archetype reasoning, and synthesis are AI-generated analysis.

Verdict

Sell

HIGH confidence

Why

Six archetypal investors unanimously rate Walmart a SELL at $103.70. The business earns respect across the panel for its cost-leadership moat, 22.3% ROE, and 23% e-commerce growth, but after a 23% drawdown the stock still commands 36x forward earnings with a 1.8% FCF yield. Nearly 3 million shares of insider selling concentrated before the post-earnings 9% drop has turned what was a patience play into an exit signal, and the decisive weekly Stage 4 breakdown below all three EMAs on heavy volume confirms that the trend, not just the valuation, is working against the stock.

Level to watch

Key support 103.69

−0.0% from 103.7

Next catalyst

Breakdown trigger to monitor: A weekly close below $95.42 would confirm the trapdoor to $87 and signal that the Stage 4 decline is accelerating rather than exhausting.

The panel's take

Verdict: SELL · Conviction: HIGH · Last price: 103.7 · Changed from WAIT

Panel: 0 Bullish · 0 Neutral · 6 Bearish → SELL

What changed since 2026-08-15:

  • Price: 115.27 → 103.7 (-10.04%)
  • Panel: 0 of 6 → 0 of 6 now Bullish — composition also changed: added The Asymmetric Bargainer, The Moat Compounder, The Scuttlebutt Growth Investor; removed The Activist Catalyst, The Margin-of-Safety Hunter, The Quality Rationalist
  • Trigger: A weekly close above $105.42 (the monthly EMA20 and horizontal resistance cluster) would be the first sign of stabilization and would pause the sell case. To genuinely flip the verdict toward a buy, the stock would need to reclaim $110.60+ (the weekly 61.8% Fib) with declining volume, accompanied by a halt in insider selling and evidence that comps are re-accelerating — but at minimum, $105.42 must be retaken for the bearish thesis to weaken.
  • Verdict: WAIT → SELL

The prior WAIT at $115.27 anticipated a pullback into $75-$90 as a buying opportunity. Two post-earnings developments converted that patience play into a sell signal: first, the disclosure of nearly 3 million shares in concentrated insider selling during the six weeks before the print introduced a management-alignment question that did not exist in August; second, the 9% single-day drop on 1.8x average volume broke the stock decisively below all three weekly EMAs, shifting the technical structure from a healthy pullback to a Stage 4 decline. The price came down as hoped, but the manner of the decline changed the character of the trade.

Six of six panelists vote Bearish — a unanimous SELL. The prior WAIT at $115.27 anticipated a pullback into $75–$90 as a buying opportunity, but that framework is withdrawn: the post-earnings 9% single-day drop, the revelation of nearly 3 million shares in insider selling by two executives in the six weeks before the print, and the decisive weekly Stage 4 breakdown below all three EMAs on 1.8x average volume have turned a "wait for a better price" story into a "sell what you hold" one. Five voices (The Moat Compounder, The Forensic Skeptic, The Intrinsic-Value Modeler, The GARP Operator, The Asymmetric Bargainer) object on price — even after a 23% drawdown, 36x forward earnings and a 1.8% FCF yield offer no margin of safety for a low-margin retailer with near-term margin headwinds. The Scuttlebutt Growth Investor's objection adds the business-conduct dimension: the insider selling concentration is a red flag on management alignment that undermines the bull case at any price until it reverses.

Key levels

Key levels · WMT

USD · as of 2026-08-22
Analyst consensus 129.18 ▲
R3115.67
+11.5%
R2110.6
+6.7%
R1105.42
+1.7%
S1103.69
−0.0%
S298.46
−5.1%
S395.42
−8.0%
NOW
103.7

Analyst consensus target 129.18 USD · range 81–155

Key support & resistance and analyst consensus — educational analysis, not advice. These are not entry or exit prices. Trading involves risk of loss.

Key support at $103.69 is the weekly 78.6% Fibonacci retracement — the immediate line in the sand where price is currently testing. Below that, $98.46 is the monthly 38.2% Fib, and $95.42 is the weekly swing low and 52-week low; a weekly close beneath it opens the path to $87.13 (monthly 50% Fib). Key resistance begins at $105.42, the monthly EMA20 and horizontal resistance cluster that every voice names as the first stabilization threshold. Above that, $110.60 is the weekly 61.8% Fib, and $115.67 is the weekly EMA20 and 50% Fib — the zone price broke decisively below on the post-earnings 9% single-day drop on 2026-08-20. The analyst consensus target of $129.18 sits 24.6% above the current price but rests on an estimate base that has seen eight downward revisions in the last 30 days.

What legendary investors think

We ran Walmart Inc. past a panel of 6 legendary investors' frameworks.

The panel · 6 investors

🟢
0
Bullish
⚫
0
Neutral
🔴
6
Bearish
The Moat CompounderValue/Quality/Moat🔴 BearishMed

Signal: Walmart's cost-leadership moat, 22.3% ROE, and 1.87x operating-cash-to-net-income ratio confirm it is a wonderful business, yet at 36x forward earnings and a 1.8% FCF yield, the price offers no margin of safety for a low-margin retailer, violating the first principle: price is what you pay, value is what you get. Conviction: Conviction is reinforced by three independent red flags: the decisive weekly Stage 4 breakdown on 1.8x average volume, nearly 3 million shares of insider selling concentrated in the six weeks before the print, and a PEG ratio north of 3x that prices in perfection for a mature stalwart.

The Forensic SkepticContrarian/Forensic🔴 BearishLow

Signal: The market treats the 9% post-earnings drop as a routine dip-buying opportunity, but at 18.9x EV/EBITDA and a 1.8% FCF yield, this remains a premium stock undergoing a sentiment correction rather than deep value, and the same-store sales miss is a genuine signal of consumer stress that management itself confirmed. Conviction: Conviction is held in check because Walmart's earnings quality is genuinely strong (the OCF-to-net-income ratio sits at 1.87x and no accounting red flags surfaced in the quarter), which limits how far the short case can run without a fundamental crack in the business.

The Intrinsic-Value ModelerValuation/DCF🔴 BearishMed

Signal: Even under generous assumptions (6% revenue CAGR, 5.5% terminal operating margins, and normalized free cash flow of $18 billion), the DCF-implied equity value lands between $72 and $86 per share, implying 17% to 31% downside from $103.70. Conviction: Conviction is tempered by a specific data gap: FY26 absolute revenue was unavailable, forcing FCF to be estimated from net income and margin, which introduces roughly ±15% potential error into the valuation range.

The GARP OperatorGrowth (GARP)🔴 BearishMed

Signal: At a PEG ratio of 3.05x, you are paying triple the earnings growth rate for an $800 billion stalwart with zero ten-bagger potential, a math problem that has rarely resolved in favor of the buyer at these levels. Conviction: What locks conviction in is the consistency of the warning signs: the PEG is stretched across both trailing and forward bases, the Stage 4 technical breakdown is confirmed by 1.8x average volume, the CFO himself is guiding to near-term margin compression, and two executives sold nearly 3 million shares before the print.

The Asymmetric BargainerContrarian/Deep Value🔴 BearishLow

Signal: This fails the Dhandho test on the criterion that matters most: at 37x trailing earnings and a 1.8% FCF yield, the downside to $78 is larger and more probable than the upside to $140, producing a negative expected value that the Patels would walk away from. Conviction: What keeps conviction moderate is the genuine quality of the underlying business: Walmart's 22.3% ROE, wide cost-leadership moat, and 23% e-commerce growth mean the stock is mispriced rather than broken, so the timing of any mean reversion remains uncertain.

The Scuttlebutt Growth InvestorGrowth/Management🔴 BearishLow

Signal: Nearly 3 million shares of insider selling by two executives, concentrated in the six weeks before a post-earnings 9% single-day drop, violates the single most important The Scuttlebutt Growth Investor criterion (management integrity) and undermines the bull case at any price until the selling reverses. Conviction: Conviction stays low because critical scuttlebutt inputs (labor relations, executive culture, management depth, and equity dilution trends) are absent from the record, and without that qualitative color a confident bearish rating on a business this strong is premature.

Each view is one investing framework applied to the stock — a perspective, not advice, and identical for every reader. Signals are the panel's own scale, not a recommendation to act.

Where they agree — and where they clash

Common ground

  • All six panelists agree the business itself is high-quality: wide cost-leadership moat, 22.3% ROE, strong operating cash flow conversion at 1.87x net income.
  • All agree the stock is overvalued at $103.70: 36x forward earnings, 1.8% FCF yield, PEG above 3x.
  • All cite the weekly Stage 4 technical breakdown below all three EMAs on 1.8x average volume as confirming near-term downside risk.
  • All flag the nearly 3 million shares of insider selling by two executives in the six weeks before earnings as a significant negative signal.
  • All acknowledge the near-term margin headwinds from tariff-refund reinvestment and consumer strain are real, not transitory noise.

The real debate

  • The Moat Compounder and The Intrinsic-Value Modeler both treat the insider selling as a yellow flag within an otherwise high-quality compounder: they would become buyers if the stock reaches $75-$90. The Scuttlebutt Growth Investor treats the same insider selling as a potential dealbreaker on management integrity that would disqualify the stock at any price until it reverses.
  • The Forensic Skeptic views the Stage 4 breakdown as a momentum-driven short opportunity with a defined downside target at $87, while The Asymmetric Bargainer sees the negative expected value but warns the business is mispriced rather than broken, making the timing of any mean reversion uncertain.

The question it comes down to: Does the concentrated insider selling signal a genuine loss of conviction by the people who know the business best, or is the 23% selloff already discounting the CFO's explicit margin-compression warning, leaving a quality compounder that is merely expensive, not deteriorating?

The bottom line

  • Breakdown trigger to monitor: A weekly close below $95.42 would confirm the trapdoor to $87 and signal that the Stage 4 decline is accelerating rather than exhausting.
  • First sign of stabilization: A weekly close above $105.42 (the monthly EMA20 and horizontal resistance cluster) would pause the bear case and suggest the selloff may be finding a floor.
  • What would flip the call: Reclaiming $110.60 or higher (the weekly 61.8% Fibonacci retracement) on declining volume, combined with a halt in insider selling and evidence of comps re-accelerating, would shift the panel toward a neutral or constructive stance.
  • Management alignment to watch: The Scuttlebutt Growth Investor's objection hinges on whether the insider selling ceases; open-market insider purchases would directly address the Scuttlebutt Growth Investor criterion on management integrity.
  • Next earnings catalyst: Q3 FY27 results (mid-November 2026) will test whether the tariff-refund margin compression the CFO guided toward actually materializes, and whether same-store sales stabilize or deteriorate further.

contact@verdixhq.com · Published 2026-08-22 · Prices as of 2026-08-22 · Time horizon: 3–12 months · No direct position held in WMT · WMT verdict history → · Methodology →

Verdix's panel is made up of AI archetypes that apply the well-documented, publicly known investment frameworks of famous investors. They are AI agents — not the investors themselves. Verdix is not affiliated with, endorsed by, or authorized by any real individual, and the archetypes do not represent any real person's actual views, holdings, or statements. Every verdict is AI-generated.

Verdix provides educational equity research and AI-generated multi-perspective analysis. Nothing here constitutes personalized investment advice or a recommendation to buy or sell any security. Verdicts are uniform across all users and do not consider your individual financial situation, risk tolerance, or objectives. Trading and investing involve substantial risk of loss. Past performance does not predict future results. Consult a licensed financial advisor before making investment decisions.

Stay ahead of WMT's next verdict

The panel's view can flip on new earnings, a guidance cut, or a valuation shift. Get the update the moment it happens — not weeks later.

One email, only on a verdict change. Unsubscribe anytime.